PAR paradigm biopharmaceuticals limited..

Morning all-adding to observations the line in the report that...

  1. 274 Posts.
    lightbulb Created with Sketch. 27
    Morning all-adding to observations the line in the report that tickled my fancy was
    "Paradigm’s focus will now shift to the initiation and recruitment of Australian patients with Knee OA for,PARA-008 which will evaluate biomarkers in PPS treated subjects, and the Pivotal Phase 3 clinical trials for drug registration."

    Almost ironic that the phase 3 trial results is an afterthought.wink.png
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
45.0¢
Change
0.020(4.65%)
Mkt cap ! $178.8M
Open High Low Value Volume
45.0¢ 45.0¢ 43.0¢ $133.2K 302.8K

Buyers (Bids)

No. Vol. Price($)
1 15521 44.5¢
 

Sellers (Offers)

Price($) Vol. No.
45.0¢ 1539 3
View Market Depth
Last trade - 10.44am 08/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.